SCL Science Appoints Lim Chong-seo to New Board of Directors... "Strengthening Digital Healthcare Capabilities"

On the 19th, SCL Science announced that it is promoting the appointment of new directors to strengthen its digital healthcare and bio-logistics businesses and improve management efficiency.

At the extraordinary general meeting scheduled for the 3rd of next month, SCL Science plans to appoint Baek Se-yeon, head of the New Drug Development Support Division at SCL Healthcare, as an inside director, and Professor Choi Jung-gyun of KAIST's Department of Bio and Brain Engineering as an outside director.

New director candidate Baek Se-yeon graduated from Ewha Womans University College of Medicine and completed a master's and doctoral program in Laboratory Medicine at Ajou University School of Medicine. Baek is a specialist in Laboratory Medicine and currently serves concurrently as head of the New Drug Development Support Division at SCL Healthcare, head of the Global Marketing Division at SCL, and director of the Future Medicine Business Office at Hanaro Medical Foundation. In 2022, Baek received a commendation from the Minister of Health and Welfare at the government awards ceremony for contributions to clinical trials.

The appointment of Director Baek is aimed at the stable growth of SCL Science’s initiatives including the △medical data marketplace △artificial intelligence (AI)-based large language model (LLM) solutions for healthcare △digital healthcare business.

As an outside director, Professor Choi Jung-gyun of KAIST’s Department of Bio and Brain Engineering will be recruited. Professor Choi identifies various disease-causing factors through AI and DNA big data analysis and discovers next-generation immuno-oncology treatment targets such as cancer vaccines and cell therapies.

This year, Professor Choi gained attention for participating in the construction of the world’s largest cancer tissue single-cell and spatial transcriptome database. Previously, he received the 'Scientist of the Month Award' and the '10th Asan Medical Award for Young Medical Scientists.'

A company official stated, "We aim to accelerate performance improvement by appointing Baek Se-yeon, who has deep insight into the core competencies of the SCL Group," adding, "Director Baek will lead projects utilizing the SCL Group’s network in medical services and medical data."

He continued, "Following the appointment of Professor Choi Jung-gyun as an outside director, we plan to strengthen the construction of a medical data center and the bioinformatics field based on data," and "We will enhance bioinformatics competitiveness by applying information technology (IT) such as AI based on the abundant data held by the SCL Group."

Last year and this year, at regular shareholders’ meetings, SCL Science added △AI-based medical solution development services △healthcare services △bio-logistics business to its business objectives.

This content was produced with the assistance of AI translation services.